EFSA Finds No Safe Level for Berberine at Any Dose: EU Prohibition Is Now the Likely Outcome
EFSA’s preliminary review has found no safe intake level for berberine at any dose, with a final opinion due early 2027 likely to trigger an EU-wide prohibition. Brands selling berberine supplements in Europe should plan reformulation ahead of that opinion.
Ashwagandha Regulation Is Escalating: What Supplement Brands Must Check Now
India’s FSSAI restricted leaf-derived ashwagandha in April 2026. The Netherlands confirmed intent to ban it. The European Parliament has scheduled a scientific expert meeting for July 14, 2026. Any supplement brand with ashwagandha in its formulations must verify root-only sourcing and monitor the July 14 meeting outcome.